Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2GMX

Selective Aminopyridine-Based C-Jun N-terminal Kinase inhibitors with cellular activity

2GMX の概要
エントリーDOI10.2210/pdb2gmx/pdb
関連するPDBエントリー2g01
分子名称Mitogen-activated protein kinase 8, C-jun-amino-terminal kinase-interacting protein 1, SULFATE ION, ... (4 entities in total)
機能のキーワードjnk1, c-jun n-terminal kinase, protein kinase jnk1 inhibitors, aminopyridine-based c-jun n-terminal kinase inhibitors, transcription
由来する生物種Homo sapiens (human)
詳細
細胞内の位置Cytoplasm (By similarity): Q9UQF2
タンパク質・核酸の鎖数4
化学式量合計89785.14
構造登録者
Abad-Zapatero, C. (登録日: 2006-04-07, 公開日: 2006-06-06, 最終更新日: 2023-08-30)
主引用文献Szczepankiewicz, B.G.,Kosogof, C.,Nelson, L.T.,Liu, G.,Liu, B.,Zhao, H.,Serby, M.D.,Xin, Z.,Liu, M.,Gum, R.J.,Haasch, D.L.,Wang, S.,Clampit, J.E.,Johnson, E.F.,Lubben, T.H.,Stashko, M.A.,Olejniczak, E.T.,Sun, C.,Dorwin, S.A.,Haskins, K.,Abad-Zapatero, C.,Fry, E.H.,Hutchins, C.W.,Sham, H.L.,Rondinone, C.M.,Trevillyan, J.M.
Aminopyridine-Based c-Jun N-Terminal Kinase Inhibitors with Cellular Activity and Minimal Cross-Kinase Activity.
J.Med.Chem., 49:3563-3580, 2006
Cited by
PubMed Abstract: The c-Jun N-terminal kinases (JNK-1, -2, and -3) are members of the mitogen activated protein (MAP) kinase family of enzymes. They are activated in response to certain cytokines, as well as by cellular stresses including chemotoxins, peroxides, and irradiation. They have been implicated in the pathology of a variety of different diseases with an inflammatory component including asthma, stroke, Alzheimer's disease, and type 2 diabetes mellitus. In this work, high-throughput screening identified a JNK inhibitor with an excellent kinase selectivity profile. Using X-ray crystallography and biochemical screening to guide our lead optimization, we prepared compounds with inhibitory potencies in the low-double-digit nanomolar range, activity in whole cells, and pharmacokinetics suitable for in vivo use. The new compounds were over 1,000-fold selective for JNK-1 and -2 over other MAP kinases including ERK2, p38alpha, and p38delta and showed little inhibitory activity against a panel of 74 kinases.
PubMed: 16759099
DOI: 10.1021/jm060199b
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (3.5 Å)
構造検証レポート
Validation report summary of 2gmx
検証レポート(詳細版)ダウンロードをダウンロード

256158

件を2026-07-08に公開中

PDB statisticsPDBj update infoContact PDBjnumon